Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Because needs vary, we recommend discussing NAD+, B12, and IV therapy with a qualified clinician before adding new supplements or injection support to your routine
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
People experiencing fatigue: B12 plays a role in energy production, and supplementation may help alleviate fatigue
5 days/week) Frequency: Once daily, 5 days per week , progressing from 1.0 mg to 1.5 mg and then 2.0 mg as shown above
Summary: Retatrutide and 5-Amino-1MQ are both unlicensed compounds in the UK retatrutide is an investigational triple incretin receptor agonist in clinical trials, whilst 5-Amino-1MQ is a research chemical with no approved human therapeutic use
Furthermore, its unique hGH-derived structure makes it a distinctly valuable research compound
